GSK plc ADR buy Citigroup Inc.
Start price
26.06.24
/
50%
€36.40
Target price
26.06.25
-
Performance (%)
-10.44%
End price
27.06.25
€32.60
Summary
This prediction ended on 27.06.25 with a price of €32.60. The prediction for GSK plc ADR disappointed with a performance of -10.44%. A total of €1.10 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | -2.846% | -2.846% | 27.807% |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% |
Comments by Citigroup_Inc_ for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten